In this issue:
The Cancer Council of Australia overhauls melanoma guidelines
European S2k guidelines for the treatment of HS
TGA registrations
New registrations
Delgocitinib cream under evaluation for chronic eczema
AusPARs for ritlecitinib & garadacimab
PBS listings
Upcoming PBAC agenda items
Recent dermatology drug approvals in the EU
BRAF inhibitor gel promising for acneiform rash
ctDNA analysis predicts resected melanoma recurrence
2026 ACD Annual Scientific Meeting
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)